Edinburgh, United Kingdom · Founded 2017 · Privately Held (backing)
Developer of a dry powder inhaler designed to assist with inhalable medications. 1nhaler is based in Edinburgh, United Kingdom and was founded in 2017. Its last reported valuation was $13.8 million in Nov 2025. It has raised $4.5 million.
Last reported valuation
$13.8M
Oct 2026
Priced at
—
Total raised
$4.5M
Last round
—
Team — not yet on record
No current team members for 1nhaler are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of 1nhaler with a free account
·Watch 1nhaler: the Monday email on marks, rounds and moves
